Amrutanjan Health Care Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amrutanjan Health Care Limited with three other companies in this sector in India: Ngl Fine Chem Ltd (2019 sales of 1.53 billion Indian Rupees [US$21.54 million] of which 100% was Pharmaceticals), Albert David Limited (3.17 billion Indian Rupees [US$44.55 million] ), and RPG Life Sciences Limited (3.30 billion Indian Rupees [US$46.42 million] ).

Sales Analysis. During the year ended March of 2019, sales at Amrutanjan Health Care Limited were 2.53 billion Indian Rupees (US$35.60 million). This is an increase of 13.5% versus 2018, when the company's sales were 2.23 billion Indian Rupees. This was the fifth consecutive year of sales increases at Amrutanjan Health Care Limited (and since 2014, sales have increased a total of 89%).